Cited by 115Pharmacology and Obesity TreatmentCoffee research and impactsComplementary and Alternative Medicine Studies

A Review of the Human Clinical Studies Involving Citrus aurantium (Bitter Orange) Extract and its Primary Protoalkaloid p-Synephrine

Open access
Stohs, Sidney J., Preuss, Harry G., Shara, Mohd·2012·International Journal of Medical Sciences

Abstract

This review summarizes the published as well as unpublished human studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine, providing information and an assessment of the safety and efficacy of these widely used products. The results of over 20 studies involving a total of approximately 360 subjects that consumed p-synephrine alone or in combination with other ingredients are reviewed and critiqued. Over 50 % of the subjects involved in these studies were overweight/obese, and approximately two-thirds of these overweight/obese subjects consumed caffeine (132-528 mg/day) in conjunction with p-synephrine (10-53 mg/day). Bitter orange/p-synephrine containing products were consumed for up to 12 weeks. Approximately 44 % of the subjects consumed a bitter orange/p-synephrine only product, while the remainder consumed a complex product that contained multiple ingredients in addition to p-synephrine. In general, bitter orange extract alone (p-synephrine) or in combination with other herbal ingredients did not produce significant adverse events as an increase in heart rate or blood pressure, or alter electrocardiographic data, serum chemistry, blood cell counts or urinalysis. p-Synephrine alone as well as in combination products were shown to increase resting metabolic rate and energy expenditure, and modest increases in weight loss were observed with bitter orange extract/p-synephrine-containing products when given for six to 12 weeks. Longer term studies are needed to further assess the efficacy of these products and affirm their safety under these conditions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7150/ijms.4446

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • No significant changes in blood pressure were found with p-synephrine (12-13 mg) and lower doses of caffeine (150-176 mg).

    “Conversely, no significant changes in BP were found with p-synephrine (12-13 mg) and lower doses of caffeine (150-176 mg).”

    From Scientific Opinion on the safety of caffeine (2015) · cites this paper as Stohs et al., 2012

  • Significant increases in systolic and diastolic blood pressure were reported for a combination of 5.5 mg p-synephrine and 5.7 mg octopamine and caffeine (239.2 mg), and a significant increase in diastolic blood pressure but not systolic blood pressure was observed with 21 mg p-synephrine and 304 mg caffeine.

    “Significant increases in SBP and DBP were also reported for a combination of 5.5 mg p-synephrine and 5.7 mg octopamine and caffeine (239.2 mg), and a significant increase in DBP, but not in SPB, was observed with 21 mg p-synephrine and 304 mg caffeine.”

    From Scientific Opinion on the safety of caffeine (2015) · cites this paper as Stohs et al., 2012

  • Significant increases in systolic and diastolic blood pressure were reported for p-synephrine from C. aurantium extracts when consumed at doses of 54 mg, but not at lower doses (13.5-50 mg).

    “Significant increases in SBP and DBP were reported for p-synephrine from C. aurantium extracts when consumed at doses of 54 mg, but not at lower doses (13.5-50 mg).”

    From Scientific Opinion on the safety of caffeine (2015) · cites this paper as Stohs et al., 2012

  • The Panel notes that none of the available studies has investigated the effects on blood pressure of single doses of caffeine alone, of p-synephrine alone, or of their combination.

    “The Panel notes that none of the available studies has investigated the effects on BP of single doses of caffeine alone, of p-synephrine alone or of their combination.”

    From Scientific Opinion on the safety of caffeine (2015) · cites this paper as Stohs et al., 2012

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 6

  1. [1]Chen JK Chen TT Zhi Shi (Fructus Aurantii Immaturus). Chinese Medical Herbology and Pharmacology City of Industry, CA USA Art of Medicine Press 2004 485 487
  2. [5]Evans RL Pho AN Roman MC Betz JM Certification of standard reference materials containing bitter orange Analyt Bioanalyt Chem 2008 391 2023 2034 18425642
  3. [14]Stohs SJ Preuss HG Shara M The safety of Citrus aurantium (bitter orange) and its primary protoalkaloid p-synephrine Phytother Res 2011 doi: 10.1002/ptr.3490 21480414 · DOI
  4. [18]Kalman DS Oxford S Schwartz HI Krieger DR A double blind clinical evaluation of the metabolic effects of Xenadrine EFXTM compared to two ephedra-containing products in normal healthy volunteers. Presented at the annual meeting of the American College of Nutrition, Abstract No. 101 J Amer Coll Nutr 2002 21 488
  5. [23]Kalman DS Comment on: An acute clinical trial evaluating the cardiovascular effects of an herbal ephedra-caffeine weight loss product in healthy overweight adults Int J Obes Relat metab Disord 2004 28 1355 1356 15365583
  6. [45]Hengtmann JH Aulepp H Pharmacokinetics and metabolism of synephrinc Arzneimittel Forschung 1978 28 2326 2331 582950

Cited by

Sorted by citations

Authors
Stohs, S. J., Preuss, H. G., & Shara, M.
Affiliations
  • CHI Health Creighton University Medical Center - Bergan Mercy (US)
  • Jordan University of Science and Technology (JO)
Corresponding author
Preuss, Harry G.
Venue
International Journal of Medical Sciences
Published
2012
Volume
9
Issue
7
Pages
527-538
ISSN
1449-1907 (ISSN-L)
OpenAlex
W2159553142
Cited by
115
References
51
Citations by year
2026: 4 · 2025: 3 · 2024: 3 · 2023: 6 · 2022: 11 · 2021: 6 · 2020: 11 · 2019: 9 · 2018: 10 · 2017: 12 · 2016: 7 · 2015: 12 · 2014: 9 · 2013: 11
FWCI
1.19
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • International Journal of Medical Sciences (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Pharmacology › Pharmacology and Obesity Treatment
  • Health Sciences › Medicine › Pharmacology › Coffee research and impacts
  • Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
Keywords
Citrus aurantium, p-synephrine, herbal supplements, caffeine, weight loss, resting metabolic rate, energy expenditure, cardiovascular safety, blood pressure, heart rate, overweight and obesity, supplement safety and efficacy
MeSH terms
Citrus, Humans, Obesity, Plant Extracts, Synephrine, Overweight

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review